SOL SpA
MIL:SOL
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
25.6
37.55
|
Price Target |
|
We'll email you a reminder when the closing price reaches EUR.
Choose the stock you wish to monitor with a price alert.
This alert will be permanently deleted.
Intrinsic Value
The intrinsic value of one SOL stock under the Base Case scenario is 28.33 EUR. Compared to the current market price of 36.45 EUR, SOL SpA is Overvalued by 22%.
The Intrinsic Value is calculated as the average of DCF and Relative values:
Valuation Backtest
SOL SpA
Uncover deeper insights with the Valuation Backtest. Learn how current stock valuations stack up against historical averages to gauge true investment potential.
Start backtest now and learn if your stock is truly undervalued or overvalued!
Stock is trading at its lowest valuation over the past 5 years.
To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.
The backtest for SOL cannot be conducted due to limitations such as insufficient data or other constraints. Please select a different stock or adjust your settings.
Fundamental Analysis
Select up to 3 indicators:
Select up to 3 indicators:
Months
Months
Months
Months
Select up to 2 periods:
Revenue & Expenses Breakdown
SOL SpA
Balance Sheet Decomposition
SOL SpA
Current Assets | 883m |
Cash & Short-Term Investments | 230.5m |
Receivables | 523.1m |
Other Current Assets | 129.4m |
Non-Current Assets | 1.2B |
Long-Term Investments | 41.7m |
PP&E | 801.4m |
Intangibles | 298.4m |
Other Non-Current Assets | 27.5m |
Current Liabilities | 423.1m |
Accounts Payable | 186.4m |
Accrued Liabilities | 103.5m |
Short-Term Debt | 57.1m |
Other Current Liabilities | 76.1m |
Non-Current Liabilities | 662.3m |
Long-Term Debt | 570.7m |
Other Non-Current Liabilities | 91.7m |
Earnings Waterfall
SOL SpA
Revenue
|
1.5B
EUR
|
Cost of Revenue
|
-387.8m
EUR
|
Gross Profit
|
1.1B
EUR
|
Operating Expenses
|
-912m
EUR
|
Operating Income
|
231.2m
EUR
|
Other Expenses
|
-90.2m
EUR
|
Net Income
|
141m
EUR
|
Free Cash Flow Analysis
SOL SpA
EUR | |
Free Cash Flow | EUR |
SOL Profitability Score
Profitability Due Diligence
SOL SpA's profitability score is 57/100. The higher the profitability score, the more profitable the company is.
Score
SOL SpA's profitability score is 57/100. The higher the profitability score, the more profitable the company is.
SOL Solvency Score
Solvency Due Diligence
SOL SpA's solvency score is 51/100. The higher the solvency score, the more solvent the company is.
Score
SOL SpA's solvency score is 51/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
SOL Price Targets Summary
SOL SpA
According to Wall Street analysts, the average 1-year price target for SOL is 38.76 EUR with a low forecast of 38.38 EUR and a high forecast of 39.9 EUR.
Dividends
Current shareholder yield for SOL is .
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
Profile
Country
Industry
Market Cap
Dividend Yield
Description
SOL SpA engages in the production, research, and distribution of industrial and medicinal gases; door-to-door medical care; and related medical equipment. The company is headquartered in Monza, Monza E Brianza. The company is also involved in the home care medical business. The Company’s product portfolio includes oxygen, nitrogen, hydrogen, argon, sulfur hexafluoride, carbon dioxide, ozone, helium and mixtures of medicinal gases, among others. Through its subsidiaries, the Company is involved in the provision of home care services, such as oxygen therapy, mechanical ventilation, diagnosis and care of obstructive sleep apnea syndrome, artificial nutrition, telemedicine, health assistance, and the prevention and treatment of skin ulcers. Additionally, it is engaged in the supply and management of medical and technological devices for home care. As of December 31, 2011, the Company had a number of subsidiaries, including Airsol BV, Biotechsol Srl, CTS Srl, Energetika ZJ doo, GTH Gaze Industriale SA, Cryolab Srl, GTS Shpk and Hydroenergy Shpk, among others.
Contact
IPO
Employees
Officers
The intrinsic value of one SOL stock under the Base Case scenario is 28.33 EUR.
Compared to the current market price of 36.45 EUR, SOL SpA is Overvalued by 22%.